STAT3 and Miyoshi myopathy: Cotargeting STAT3 and MEK/ERK or RAS/mitogen-activated protein kinase (MAPK) pathway produces synergistic effects and leads to the robust induction of apoptosis in MM cells grown with BMSCs [40,41].